Median Value for Cyclin E and p27
| . | Cyclin E % . | (n) . | P Value . | p27 % . | (n) . | P Value . |
|---|---|---|---|---|---|---|
| ≤65 yr | 5.0 | (52) | 32 | (53) | ||
| >65 yr | 5.5 | (46) | .88 | 25 | (47) | .05 |
| Indolent | 2.0 | (45) | 42 | (46) | ||
| Aggressive | 7.8 | (53) | <.001 | 20 | (54) | .004 |
| LDH ≤8 μkat/L | 4.5 | (61) | 37 | (63) | ||
| LDH >8 μkat/L | 6.0 | (37) | .18 | 24 | (37) | .03 |
| Stage I | 9.0 | (19) | 33 | (21) | ||
| II | 9.6 | (15) | 20 | (15) | ||
| III | 4.6 | (16) | 25 | (15) | ||
| IV | 5.4 | (48) | .006 | 39 | (49) | .21 |
| All lymphomas | 5.3 | (98) | 30 | (100) |
| . | Cyclin E % . | (n) . | P Value . | p27 % . | (n) . | P Value . |
|---|---|---|---|---|---|---|
| ≤65 yr | 5.0 | (52) | 32 | (53) | ||
| >65 yr | 5.5 | (46) | .88 | 25 | (47) | .05 |
| Indolent | 2.0 | (45) | 42 | (46) | ||
| Aggressive | 7.8 | (53) | <.001 | 20 | (54) | .004 |
| LDH ≤8 μkat/L | 4.5 | (61) | 37 | (63) | ||
| LDH >8 μkat/L | 6.0 | (37) | .18 | 24 | (37) | .03 |
| Stage I | 9.0 | (19) | 33 | (21) | ||
| II | 9.6 | (15) | 20 | (15) | ||
| III | 4.6 | (16) | 25 | (15) | ||
| IV | 5.4 | (48) | .006 | 39 | (49) | .21 |
| All lymphomas | 5.3 | (98) | 30 | (100) |
The number of patients are denoted in parentheses. Differences between subgroups were calculated with Kruskal-Wallis test.